https://www.sciencedaily.com/releases/2023/01/230118092036.htm
0
0
69 words
0
Comments
Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation chemotherapy combined with temozolomide is the standard line of treatment, GBM cells surviving radiotherapy contribute to tumor progression and recurrence…
You are the first to view
Create an account or login to join the discussion